Search Within

Nancy Kernan

  1. "Immunology Program Faculty"
Formats
  1. Meeting Abstract (173)
  2. Journal Article (93)
  3. Conference Paper (10)
  4. Book Section (1)
Groups
  1. GSK Faculty (277)
  2. Immunology Program Faculty (277)
  3. Pediatrics, Department of (277)
  4. Sloan Kettering Institute Faculty (277)
  5. Stem Cell Transplantation and Cellular Therapy Service (277)
  6. Department of Medicine (276)

More Groups

People
  1. Richard O'Reilly (270)
  2. Farid Boulad (177)
  3. Trudy Small (139)
  4. Esperanza Papadopoulos (116)
  5. Hugo Castro-Malaspina (116)
  6. Susan Prockop (115)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (4)
  4. 2022 (2)
  5. 2021 (1)
  6. 2020 (12)

More Years

Publications
  1. Blood (127)
  2. Biology of Blood and Marrow Transplantation (57)
  3. Bone Marrow Transplantation (20)
  4. Experimental Hematology (7)
  5. Transplantation (7)
  6. New England Journal of Medicine (4)

More Publications

Publishers
  1. American Society of Hematology (130)
  2. Elsevier Inc. (68)
  3. Nature Publishing Group (21)
  4. Lippincott Williams & Wilkins (9)
  5. Elsevier Science, Inc. (7)
  6. John Wiley & Sons (6)

More Publishers

Results (277)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Allogeneic or autologous stem cell transplantation (SCT) for the treatment of pediatric patients with non-Hodgkins lymphoma (NHL)
    Meeting Abstract

    Ricafort, R.; Trippett, T.; Kernan, N. A.; Small, T. N.; Prockop, S.; Scaradavou, A.; Keating, A.; O'Reilly, R. J.; Boulad, F.
    Blood (2005)

    Fulltext@MSK | Save
  • Response to immunizations following allogeneic HCT with adjuvant rituximab therapy
    Meeting Abstract

    Pao, M.; Papadopoulos, E. B.; Boulad, F.; Castro-Malaspina, H.; Jakubowski, A.; Kernan, N. A.; Perales, M.; Prockop, S.; Ford, R.; Young, J. W.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Fludarabine-based conditioning secures engraftment of secondary hematopoietic stem cell allografts (HSCT) used to treat graft failure
    Meeting Abstract

    Chewning, J. H.; Castro-Malaspina, H. R.; Hsu, K.; Jakubowski, A. A.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M. A.; Prockop, S. E.; Small, T. N.; van den Brink, M. R. M.; more...
    Biology of Blood and Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • Induction of remission prior to transplantation improves the disease-free survival (DFS) of patients with advanced myelodysplastic syndromes (MDS) treated with myeloablative T-cell depleted (TCD) stem cell transplants (SCT) from HLA identical siblings
    Meeting Abstract

    Castro-Malaspina, H. R.; Jakubowski, A. A.; Papadopoulos, E. B.; Boulad, F.; Young, J. W.; Kernan, N. A.; Perales, M. A.; Small, T. N.; Hsu, K. C.; Chiu, M.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • High dose Busulfan and fFludarabine with anti-thymocyte globulin (ATG) followed by unmodified marrow grafts from HLA-matched siblings for the treatment of high risk hemoglobinopathies (HGBpathies)
    Meeting Abstract

    Boulad, F.; Kernan, N. A.; Small, T. N.; Chewning, J.; Prockop, S.; Scaradavou, A.; Keating, A.; O'Reilly, R. J.
    Blood (2005)

    Fulltext@MSK | Save
  • Ten allele high-resolution DNA typing has a direct impact on the disease free survival (DFS) in pediatric recipients of T-cell depleted (TCD) unrelated donor (URD) hematopoietic stem cell transplant (HCT)
    Meeting Abstract

    Prasad, V. K.; Selvakumar, A.; Dastigir, H.; Boulad, F.; Small, T. N.; Prockop, S.; Dupont, B.; O'Reilly, R. J.; Kernan, N. A.
    Biology of Blood and Marrow Transplantation (2004)

    Fulltext@MSK | Save
  • Vaccine reponses following unmodified or T cell depleted unrelated and mismatched related HCT
    Meeting Abstract

    Small, T. N.; Papadopoulos, E. B.; Boulad, F.; Kernan, N. A.; Ford, R.; Taylor, J.; Casson, A.; Torok-Castanza, J.; Cuello, B.; Young, J. W.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • A phase II trial of a non-myeloablative regimen combining in vivo T cell depletion with an anti-CD52 monoclonal antibody (alemtuzumab), and chemotherapy with fludarabine and melphalan prior to a related or unrelated hematopoietic stem cell transplantation
    Meeting Abstract

    Castro-Malaspina, H.; Papadopoulos, E.; Jakubowski, A.; Perales, M. A.; Young, J.; Hsu, K.; Boulad, F.; Prasad, V.; Small, T.; Kernan, N.; more...
    Biology of Blood and Marrow Transplantation (2004)

    Fulltext@MSK | Save
  • Allogeneic bone marrow transplantation (BMT) for the treatment of children with very high risk acute lymphoblastic leukemia (ALL) in first remission (CR1)
    Meeting Abstract

    Boulad, F.; Steinherz, P.; Kernan, N. A.; Small, T. N.; Prasad, V.; Prockop, S.; Kolb, A.; O'Reilly, R. J.
    Biology of Blood and Marrow Transplantation (2004)

    Fulltext@MSK | Save
  • A phase II trial of busulfan, melphalan, and fludarabine followed by allogeneic T-cell depleted hematopoietic stem cell transplants from HLA-identical, or HLA-non identical related or unrelated donors for the treatment of advanced hematopoietic malignancies
    Meeting Abstract

    Boulad, F.; Jakubowski, A.; Castro-Malaspina, H.; Hsu, K. C.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M. A.; Prockop, S. E.; Small, T. N.; van den Brink, M. R. M.; more...
    Blood (2004)

    Fulltext@MSK | Save